This is a demo store. No orders will be fulfilled.

TAK-901, 丝氨酸/苏氨酸蛋白激酶 Aurora-B 抑制剂

Aurora A Selective Inhibitors
    级别和纯度:
  • 10mM in DMSO
  • CAS编号: 934541-31-8
  • 分子式: C28H32N4O3S
  • 分子量: 504.66
有货

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
T407937-1ml
1ml 现货 Stock Image
查看相关系列
Compound libraries (12333)

基本描述

英文别名 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide
规格或纯度 10mM in DMSO
英文名称 TAK-901
生化机理 TAK-901 是一种新型 Aurora A/B 抑制剂,IC50 为 21 nM/15 nM。它不是细胞 JAK2、c-Src 或 Abl 的强效抑制剂。第一阶段
储存温度 -80℃储存
运输条件 超低温冰袋运输
作用类型 抑制剂
作用机制 丝氨酸/苏氨酸蛋白激酶 Aurora-B 抑制剂
产品介绍

TAK-901是多靶点的的极光激酶 (aurora)抑制剂,对极光激酶A和B的IC50 值分别为21 和15 nM。

Information

TAK-901 is a novel inhibitor ofAurora A/BwithIC50of 21 nM/15 nM. It is not a potent inhibitor of cellular JAK2, c-Src or Abl. Phase 1.
In vitro

TAK-901 inhibits Aurora A-TPX2 and Aurora B-INCENP in tight binding, time-dependent manner. Dissociation of TAK-901 from Aurora B-INCENP is slow with at 1/2 of 920 minutes, and the affinity constant for TAK-901 binding to Aurora B-INCENP is determined to be 0.02 nM. TAK-901 induces inhibition of cell proliferation in cultured human cancer cell lines from different tissues with IC50s ranging from 40 to 500nM. Consistent with Aurora B inhibition, TAK-901 treatment produces polyploidy in human PC3 prostate cancer and HL60 acute myeloid leukemia cells as measured by immunofluorescence and flow cytometry. Examination of a broad panel of kinases reveals that multiple kinases, including FLT3, FGFR and the Src family kinases, are inhibited by TAK-901 with IC50 values similar to those for Aurora A and B. In cells, TAK-901 suppresses the Flt3 and FGFR2 autophosphorylation with IC50 values close to that of Aurora B as measured by cellular histone H3 phosphorylation, whereas the IC50s for inhibition of cellular Src and Bcr Abl are 20-fold weaker. In a panel of pathway specific reporter-based cell models, TAK-901 inhibits the NFkB and JAK/STAT pathways with submicromolar potency.

In vivo


Cell Data

cell lines:

Concentrations:

Incubation Time:

Powder Purity:≥97%

产品属性

ALogP 4.5

关联靶点(人)

ERCC2 Tchem 通用转录和DNA修复因子IIH解旋酶亚基XPD(General transcription and DNA repair factor IIH helicase subunit XPD) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
EPHA4 Tchem 肝素 A 型受体 4(Ephrin type-A receptor 4) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
YES1 Tclin 酪氨酸蛋白激酶 是(Tyrosine-protein kinase Yes) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
IRAK3 Tchem 白细胞介素-1受体相关激酶3(Interleukin-1 receptor-associated kinase 3) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
BCR Tclin 断点簇区域蛋白质(Breakpoint cluster region protein) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
AURKA Tchem 极光激酶A(Aurora kinase A) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PRKAG2 Tchem 5'-AMP活化蛋白激酶亚基γ-2(5'-AMP-activated protein kinase subunit gamma-2) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

名称和识别符

分子类型 小分子
Isomeric SMILES CCS(=O)(=O)C1=CC=CC(=C1)C2=CC(=C(C3=C2C4=C(N3)N=CC(=C4)C)C)C(=O)NC5CCN(CC5)C
PubChem CID 16124208
分子量 504.66

化学和物理性质

溶解性 Solubility (25°C) In vitro DMSO: 63 mg/mL (200.72 mM); Ethanol: 24 mg/mL (76.46 mM); Water: Insoluble;

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

溶液计算器